Business Description
Algorae Pharmaceuticals Ltd
ISIN : AU0000296022
Compare
Compare
Traded in other countries / regions
1AI.AustraliaLHI0.GermanyLVCLF.USA IPO Date
2004-09-01Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.3 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | 41.5 | |||||
| 3-Year Book Growth Rate | -26.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.44 | |||||
| 9-Day RSI | 47.37 | |||||
| 14-Day RSI | 48.64 | |||||
| 6-1 Month Momentum % | -25 | |||||
| 12-1 Month Momentum % | 12.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 26.84 | |||||
| Quick Ratio | 26.84 | |||||
| Cash Ratio | 25.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.1 | |||||
| Shareholder Yield % | -2.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -66.8 | |||||
| ROA % | -60.93 | |||||
| ROIC % | -5898.31 | |||||
| ROC (Joel Greenblatt) % | -18810.81 | |||||
| ROCE % | -66.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5 | |||||
| EV-to-EBIT | -5.71 | |||||
| EV-to-EBITDA | -5.71 | |||||
| EV-to-FCF | -7.95 | |||||
| Earnings Yield (Greenblatt) % | -17.5 | |||||
| FCF Yield % | -10.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Algorae Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.002 | ||
| Beta | 0.37 | ||
| Volatility % | 60.69 | ||
| 14-Day RSI | 48.64 | ||
| 14-Day ATR (A$) | 0.001127 | ||
| 20-Day SMA (A$) | 0.01015 | ||
| 12-1 Month Momentum % | 12.5 | ||
| 52-Week Range (A$) | 0.008 - 0.017 | ||
| Shares Outstanding (Mil) | 1,661.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Algorae Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Algorae Pharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Algorae Pharmaceuticals Ltd Frequently Asked Questions
What is Algorae Pharmaceuticals Ltd(ASX:1AI)'s stock price today?
The current price of ASX:1AI is A$0.01. The 52 week high of ASX:1AI is A$0.02 and 52 week low is A$0.01.
When is next earnings date of Algorae Pharmaceuticals Ltd(ASX:1AI)?
The next earnings date of Algorae Pharmaceuticals Ltd(ASX:1AI) is .
Does Algorae Pharmaceuticals Ltd(ASX:1AI) pay dividends? If so, how much?
Algorae Pharmaceuticals Ltd(ASX:1AI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers